Ultragenyx Pharmaceutical (RARE) Shareholder's Equity Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -263.89% |
| Dec 31, 2025 | -131.37% |
| Sep 30, 2025 | -97.36% |
| Jun 30, 2025 | -65.01% |
| Mar 31, 2025 | 2.66% |
| Dec 31, 2024 | -7.27% |
| Sep 30, 2024 | 993.61% |
| Jun 30, 2024 | 235.13% |
| Mar 31, 2024 | -36.38% |
| Dec 31, 2023 | -21.88% |
| Sep 30, 2023 | -93.24% |
| Jun 30, 2023 | -80.97% |
| Mar 31, 2023 | -72.32% |
| Dec 31, 2022 | -61.85% |
| Sep 30, 2022 | -49.79% |
| Jun 30, 2022 | -30.25% |
| Mar 31, 2022 | -24.48% |
| Dec 31, 2021 | -20.08% |
| Sep 30, 2021 | 40.15% |
| Jun 30, 2021 | 39.76% |
| Mar 31, 2021 | 73.12% |
| Dec 31, 2020 | 76.57% |
| Sep 30, 2020 | -8.40% |
| Jun 30, 2020 | -15.15% |
| Mar 31, 2020 | -31.30% |
| Dec 31, 2019 | 7.37% |
| Sep 30, 2019 | 9.76% |
| Jun 30, 2019 | 16.45% |
| Mar 31, 2019 | 22.53% |
| Dec 31, 2018 | 58.80% |
| Sep 30, 2018 | 81.26% |
| Jun 30, 2018 | 63.92% |
| Mar 31, 2018 | 48.15% |
| Dec 31, 2017 | -19.10% |
| Sep 30, 2017 | -19.81% |
| Jun 30, 2017 | -3.25% |
| Mar 31, 2017 | 530,854.35% |
| Dec 31, 2016 | -10.75% |
| Sep 30, 2016 | -20.96% |
| Jun 30, 2016 | 39.03% |
| Mar 31, 2016 | -99.97% |
| Dec 31, 2015 | 187.16% |
| Sep 30, 2015 | 189.36% |
| Jun 30, 2015 | 108.57% |
| Mar 31, 2015 | 105.85% |
| Dec 31, 2014 | 347.18% |